Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.
about
Intra-arterial chemotherapy for high-grade gliomasThe natural history of EGFR and EGFRvIII in glioblastoma patientsRecurrent Glioblastoma: Where we standOccludin expression in microvessels of neoplastic and non-neoplastic human brainThe comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkersEvidence from a large-scale meta-analysis indicates eczema reduces the incidence of gliomaSurvival in glioblastoma: a review on the impact of treatment modalities.Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.Investigation of serum proteome alterations in human glioblastoma multiforme.Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.Association between EGF +61 G/A and glioma risk in a Chinese population.MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.Spinal Intradural Intramedullary Dissemination in the Absence of Intracranial Relapse of a Previously Radically Treated Temporal Lobe Glioblastoma MultiformeAffinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma MultiformeBoron neutron capture therapy for malignant gliomas.On the validity of using increases in 5-year survival rates to measure success in the fight against cancerThe proteomic response in glioblastoma in young patientsProgress in active-specific immunotherapy of brain malignancies.Brain tumors in the older person.Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?Population-based survival data for brain tumors in Korea.Surgical resection of malignant gliomas-role in optimizing patient outcome.Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis.Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction.TWIST is expressed in human gliomas and promotes invasion.Clinical development of experimental therapies for malignant glioma.Local treatment of brain tumors with targeted chimera cytotoxic proteins.Oncolytic adenoviruses for treatment of brain tumours.Incidence of primary spinal cord, spinal meninges, and cauda equina tumors in Korea, 2006-2010.Brain tumours in Sweden 1996: care and costs.Design and application of oncolytic HSV vectors for glioblastoma therapy.Novel chemotherapeutic agents for the treatment of glioblastoma multiforme.Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registriesIL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion.
P2860
Q24202500-B4BA7D1F-D267-497B-B598-7EB66EC4EE2FQ24814477-E84F5972-8980-4A44-8265-BB3D5A9FD062Q26765042-3A3E0553-B67F-477E-9729-DE00598EB84AQ28202259-19C185BD-6567-4587-ACE8-A330DA4C5F76Q28608269-15245082-582D-4402-9500-7E1763A5E285Q29248257-873EB137-E0E1-4AC2-97CB-5E2C84A9E577Q30251810-09256F46-FEA7-4A9F-B659-46BEE3EBA254Q30481789-1A3519B7-2B8A-4E66-BBC9-DEEAE5ECD971Q30571373-F6E820FC-D92A-45DE-A815-8085B1899B18Q31063977-3B46A3A0-12BB-4DD7-B320-22FE594F94F8Q33539532-F0CCE3BF-9E44-4C04-A2F6-86F7CA72A3B2Q33582843-A3850424-8331-4F1F-9373-176166CB4407Q33618467-0EECC571-E781-4D7A-B79A-91D050C45FAEQ33650877-C7E4DBAA-47D2-4F96-ABF9-F55533BEA3F5Q33687487-5C7F9903-308B-476F-98B2-9ED35D2F412CQ33832441-6C261977-DD0F-4A30-91C6-EE98B7B0912EQ33859666-028FD797-CE42-4202-914B-3095DB5CFDEFQ33939888-6E5A704D-10BC-4ECE-98CD-943B8DE2781FQ34030167-0EBA9A6D-690D-4D48-A3EE-24B6F6F5DB73Q34075068-7A2FB30B-BE77-4681-BA41-C8FB9E11F1ADQ34087862-72428662-C5DB-452D-8FF2-01BC172D998DQ34132860-02E8065C-6255-4CC4-BB52-704CF658D4AFQ34290509-99A80BB5-235D-465E-A11C-DD9BDB777434Q34324963-764EFFA4-E010-494D-8080-9EDC083DBD48Q34331925-3222B344-EDA9-4E1A-A63E-F0E93D8A3D06Q34365378-42B2AA84-EF35-4BCC-AA2A-96528D8D3153Q34381483-7E366D07-0B7D-4704-BD2C-860DBFCCA993Q34769731-3DD13C16-D384-4B6E-B1EE-4E1ED5B6E9B0Q34782295-12612783-1A35-4449-BF1E-9F49C52E077DQ34798727-BFD1097B-9C4C-4939-8CFB-AE84DA8CF242Q35040863-A7D9EBE5-2125-4F53-897C-799DBED16E43Q35429959-72D90E09-4378-4E5B-9A58-94C6D2B7C466Q35459947-E5BFBCF3-87B4-406D-A038-4A9D37AC6D62Q35559877-FAD0E108-E636-44A0-979A-70C8E542DC89Q35594029-7221596E-7AA0-49D3-BF5F-807A307EDD12Q35605776-BD6DAF59-AE2B-4787-BE5E-2DF59F21085EQ35626536-D85D717C-12CB-476B-B702-CAD1405C78C5Q35800509-695402EF-6BA7-40AC-A48F-39E15A756A83Q35800526-EF9387AD-FCB0-41A7-BABA-A9929BC33094Q35879993-AF7E8469-2291-4F2D-A8ED-0A98BA52AC3F
P2860
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@ast
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@en
type
label
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@ast
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@en
prefLabel
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@ast
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@en
P2093
P1476
Survival rates in patients wit ...... esults (SEER) data, 1973-1991.
@en
P2093
P356
10.3171/JNS.1998.88.1.0001
P577
1998-01-01T00:00:00Z